Amir Taherkhani

43.0k total citations
53 papers, 507 citations indexed

About

Amir Taherkhani is a scholar working on Molecular Biology, Computational Theory and Mathematics and Cancer Research. According to data from OpenAlex, Amir Taherkhani has authored 53 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Computational Theory and Mathematics and 9 papers in Cancer Research. Recurrent topics in Amir Taherkhani's work include Computational Drug Discovery Methods (12 papers), Ferroptosis and cancer prognosis (6 papers) and Oral microbiology and periodontitis research (4 papers). Amir Taherkhani is often cited by papers focused on Computational Drug Discovery Methods (12 papers), Ferroptosis and cancer prognosis (6 papers) and Oral microbiology and periodontitis research (4 papers). Amir Taherkhani collaborates with scholars based in Iran, United States and Italy. Amir Taherkhani's co-authors include Zahra Khamverdi, Massoud Saidijam, Afsaneh Arefi Oskouie, Hamid Sohanaki, Seyed Amir Ghiasian, Ali Mohammad Alizadeh, Maryam Roudbary, Gholamreza Roshandel, Shahryar Semnani and Hamed Manoochehri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and BioMed Research International.

In The Last Decade

Amir Taherkhani

46 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir Taherkhani Iran 13 205 112 67 53 49 53 507
Hanan Elimam Egypt 15 263 1.3× 54 0.5× 151 2.3× 48 0.9× 40 0.8× 60 709
Jixia Li China 15 347 1.7× 67 0.6× 103 1.5× 17 0.3× 55 1.1× 43 673
Menna El Gaafary Germany 11 315 1.5× 67 0.6× 43 0.6× 20 0.4× 30 0.6× 19 535
Verónica Rocío Vásquez-Garzón Mexico 17 309 1.5× 92 0.8× 78 1.2× 17 0.3× 103 2.1× 46 727
Judit Mihaly‐Bison Austria 10 308 1.5× 141 1.3× 107 1.6× 32 0.6× 26 0.5× 13 622
Shengnan Li China 15 230 1.1× 41 0.4× 45 0.7× 24 0.5× 31 0.6× 33 709
Liting Huang China 12 236 1.2× 47 0.4× 48 0.7× 12 0.2× 26 0.5× 29 484
Kamal Dua Australia 11 332 1.6× 80 0.7× 182 2.7× 24 0.5× 60 1.2× 20 661

Countries citing papers authored by Amir Taherkhani

Since Specialization
Citations

This map shows the geographic impact of Amir Taherkhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Taherkhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Taherkhani more than expected).

Fields of papers citing papers by Amir Taherkhani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Taherkhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Taherkhani. The network helps show where Amir Taherkhani may publish in the future.

Co-authorship network of co-authors of Amir Taherkhani

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Taherkhani. A scholar is included among the top collaborators of Amir Taherkhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Taherkhani. Amir Taherkhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Taherkhani, Amir, et al.. (2024). Potential JAK2 Inhibitors from Selected Natural Compounds: A Promising Approach for Complementary Therapy in Cancer Patients. Evidence-based Complementary and Alternative Medicine. 2024. 1–20. 2 indexed citations
4.
Taherkhani, Amir, et al.. (2024). Malignant Transformation of Normal Oral Tissue to Dysplasia and Early Oral Squamous Cell Carcinoma: An In Silico Transcriptomics Approach. Analytical Cellular Pathology. 2024(1). 6260651–6260651.
5.
Taherkhani, Amir, et al.. (2024). Natural Anthraquinones as Potential Akt1-Targeted Anticancer Agents. SHILAP Revista de lepidopterología. 12(2). 123–130.
7.
Taherkhani, Amir, et al.. (2024). Targeting Matrix Metalloproteinase‐3 for Dental Caries Prevention Using Herbal Isolates: MMP3 Inhibition by Cinnamic Acids. International Journal of Dentistry. 2024(1). 9970824–9970824. 1 indexed citations
8.
Rostami, Ali, et al.. (2023). Exploring natural anthraquinones as potential MMP2 inhibitors: A computational study. Biosystems. 235. 105103–105103. 3 indexed citations
9.
Taherkhani, Amir, et al.. (2023). A systems biology approach to uncover key genes and pathways mediating progression of leukoplakia to primary oral squamous cell carcinoma. Journal of Oral and Maxillofacial Surgery Medicine and Pathology. 36(1). 120–132. 2 indexed citations
10.
Taherkhani, Amir, et al.. (2023). Cinnamic acids as promising bioactive compounds for cancer therapy by targeting MAPK3: a computational simulation study. Journal of Complementary and Integrative Medicine. 20(3). 621–630. 6 indexed citations
11.
Taherkhani, Amir, et al.. (2023). Natural Anthraquinones as Promising MAPK3 Inhibitors for Complementary Cancer Therapy. Journal of Chemistry. 2023. 1–13. 5 indexed citations
12.
Taherkhani, Amir, et al.. (2023). Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach. International Journal of Analytical Chemistry. 2023. 1–16. 16 indexed citations
13.
Saidijam, Massoud, et al.. (2023). Prognostic biomarkers and molecular pathways mediating Helicobacter pylori–induced gastric cancer: a network-biology approach. Genomics & Informatics. 21(1). e8–e8. 2 indexed citations
14.
Taherkhani, Amir, et al.. (2022). Identification of Potential Anti-tooth-decay Compounds From Organic Cinnamic Acid Derivatives by Inhibiting Matrix Metalloproteinase-8: An In Silico Study. Avicenna journal of dental research. 14(1). 25–32. 7 indexed citations
15.
Rezaei–Tavirani, Mostafa, et al.. (2021). Screening of Altered Metabolites and Metabolic Pathways in Celiac Disease Using NMR Spectroscopy. BioMed Research International. 2021(1). 1798783–1798783. 9 indexed citations
17.
Taherkhani, Amir, et al.. (2021). In silico Study of Some Natural Anthraquinones on Matrix Metalloproteinase Inhibition. SHILAP Revista de lepidopterología. 8(4). 37–51. 10 indexed citations
18.
Manoochehri, Hamed, et al.. (2021). Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data. Journal of Gastrointestinal Cancer. 53(3). 649–668. 21 indexed citations
19.
Taherkhani, Amir, et al.. (2020). Molecular docking study of flavonoid compounds for possible matrix metalloproteinase-13 inhibition. Journal of Basic and Clinical Physiology and Pharmacology. 32(6). 1105–1119. 23 indexed citations
20.
Taherkhani, Amir, et al.. (2020). Molecular Docking Analysis of Flavonoid Compounds with Matrix Metalloproteinase- 8 for the Identification of Potential Effective Inhibitors. Letters in Drug Design & Discovery. 18(1). 16–45. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026